These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 4370270)

  • 21. [On the problem of revaccination against poliomyelitis. Results of a reinfection experiment using the poliovirus type 1, strain "LSc, 2ab (Sabin)". 4 and half years following original vaccination].
    Kuwert E; Posch J; Lagarie G
    Med Klin; 1968 May; 63(18):701-7. PubMed ID: 4305218
    [No Abstract]   [Full Text] [Related]  

  • 22. [Poliomyelitis--why we must continue to vaccinate!].
    Windorfer A; Beyrer K
    MMW Fortschr Med; 2005 Feb; 147(8):36, 38, 40. PubMed ID: 18437859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliomyelitis: immunization/prophylaxis for children and adolescents.
    Nurse Pract; 1997 Sep; 22(9):104, 111, 115-7. PubMed ID: 9314168
    [No Abstract]   [Full Text] [Related]  

  • 24. Experience of vaccination with inactivated poliomyelitis vaccines in Iceland.
    Gudnadóttir M
    Dev Biol Stand; 1981; 47():257-9. PubMed ID: 7227654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus.
    Ogra PL
    N Engl J Med; 1971 Jan; 284(2):59-64. PubMed ID: 4321186
    [No Abstract]   [Full Text] [Related]  

  • 26. [Serum conversion rate following oral poliomyelitis immunization in Mali, Africa 1982].
    Ehrengut W; AgRhaly A; Koch I; Koumaré B; Simaga SY; Diallo D
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):29-31. PubMed ID: 6321963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary immunization and booster vaccination against polio].
    Müller HE
    Dtsch Med Wochenschr; 1995 May; 120(21):776. PubMed ID: 7781504
    [No Abstract]   [Full Text] [Related]  

  • 28. [Characteristics of the dynamics of herd immunity to the poliovirus and of the quality of the vaccination carried out against poliomyelitis].
    Vlasova LV; Vaserin IuI; Stepanova GP; Zakirova SF; Venediktova NIa
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):75-8. PubMed ID: 6303022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parameters (r-value of the immunity status, cumulative vaccination participation, index of the relative vaccination participation) for the surveillance of poliomyelitis in a city of the Ruhr-area].
    Höher PG; Thraenhart O; Kuwert E; Bohlmann HG; Worringen W; Lagarie GW
    Zentralbl Bakteriol Orig B; 1973 Feb; 156(6):471-85. PubMed ID: 4713086
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
    Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
    Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. I. Vaccination with the WM3 strain in 20 families.
    Böttiger M; Lagercrantz R
    J Pediatr; 1969 Jul; 75(1):30-8. PubMed ID: 4307138
    [No Abstract]   [Full Text] [Related]  

  • 32. [Poliomyelitis in Poland in the years 1971-1972].
    Kulesza A
    Przegl Epidemiol; 1973; 27(4):527-32. PubMed ID: 4359971
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 34. Statement on poliomyelitis vaccination for international travellers (evidence-based medicine recommendations). Committee to Advise on Tropical Medicine and Travel (CATMAT).
    Can Commun Dis Rep; 1995 Aug; 21(16):145-8. PubMed ID: 7581211
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance of enterovirus infections in Bangkok. I. Isolation of enterovirus from faecal specimens of healthy children.
    Sangkawibha N; Tuchinda P; Sakuntanaga P; Sunthornsaratul A
    Southeast Asian J Trop Med Public Health; 1975 Mar; 6(1):3-9. PubMed ID: 167453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of routine polio immunization in the post-certification era.
    Sutter RW; Cáceres VM; Mas Lago P
    Bull World Health Organ; 2004 Jan; 82(1):31-9. PubMed ID: 15106298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poliomyelitis in Rio de Janeiro during the period of 1970 to 1974. I. Virological and epidemiological aspects.
    Von Hubinger MG; Meilman I; Guimarães JC; De Vascancelos CM; Liberto MI
    An Microbiol (Rio J); 1978; 23():35-50. PubMed ID: 233609
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serological and epidemiological effects of Salk vaccination against poliomyelitis in Tyrol].
    Bauer P; Schinzel A
    Arch Hyg Bakteriol; 1968 Dec; 152(5):400-4. PubMed ID: 5741511
    [No Abstract]   [Full Text] [Related]  

  • 39. [Poliomyelitis vaccination in France in children under 6 years of age].
    Celers
    Pediatrie; 1976 Dec; 31(8):809-14. PubMed ID: 1005013
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral poliomyelitis immunization. Comparison of the serological findings after two- and threefold application of a trivalent live vaccine].
    Kuwert E; Höher PG; Worringen W; Bohlmann HG; Thraenhart O
    Dtsch Med Wochenschr; 1970 Dec; 95(50):2505-9. PubMed ID: 5484755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.